Higher rates of neuropsychiatric adverse events leading to dolutegravir discontinuation in women and older patients

被引:0
|
作者
Sabranski, Michael [1 ]
Wyen, Christoph [2 ]
Hoffmann, Christian [1 ]
Welz, Tanya [2 ]
Kolb, Michael [2 ]
Wolf, Eva [3 ]
Stellbrink, Hans-Juergen [1 ]
机构
[1] ICH Study Ctr Hamburg, Infect Dis, Hamburg, Germany
[2] Praxis Ebertplatz, Infect Dis, Cologne, Germany
[3] MUC Res, Infect Dis, Munich, Germany
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
O214
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Safety analysis of German real-life cohort WIP shows rates of neuropsychiatric events leading to discontinuation of raltegravir therapy below 2%
    Naumann, U.
    Moll, A.
    Schleehauf, D.
    Lutz, K. T.
    Schmidt, W.
    Jaeger, H.
    Funke, B.
    Witte, V.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2019, 30 (07) : 727 - 728
  • [22] Anticholinergic Activity of Commonly Prescribed Medications and Neuropsychiatric Adverse Events in Older People
    Nishtala, Prasad S.
    Fois, Romano A.
    McLachlan, Andrew J.
    Bell, J. Simon
    Kelly, Patrick J.
    Chen, Timothy F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (10): : 1176 - 1184
  • [23] Aspirin discontinuation raises the risk of adverse events in patients with CAD
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (2): : 66 - 67
  • [24] ANEUPLOIDY IN OLDER WOMEN - HIGHER RATES OF ANEUPLOIDY IN OOCYTES FROM OLDER WOMEN
    ANGELL, RR
    HUMAN REPRODUCTION, 1994, 9 (07) : 1199 - 1200
  • [25] Low-grade cutaneous immune-related adverse events leading to immunotherapy discontinuation
    Jacoby, Ted V.
    Asdourian, Maria S.
    Shah, Nishi
    Otto, Tracey S.
    Thompson, Leah L.
    Reynolds, Kerry L.
    Chen, Steven T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (09) : 1058 - 1060
  • [26] ADVERSE DRUG EVENTS WITH WARFARIN IN OLDER PATIENTS
    Prkacin, I.
    Habek, J. Cerkez
    THROMBOSIS RESEARCH, 2014, 133 : S46 - S46
  • [27] Analysis of Neuropsychiatric Adverse Events in Patients Treated with Oseltamivir in Spontaneous Adverse Event Reports
    Ueda, Natsumi
    Umetsu, Ryogo
    Abe, Junko
    Kato, Yamato
    Nakayama, Yoko
    Kato, Zenichiro
    Kinosada, Yasutomi
    Nakamura, Mitsuhiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (10) : 1638 - 1644
  • [28] Low grade cutaneous immune related adverse events leading to immune checkpoint inhibitor discontinuation
    Jacoby, T. V.
    Asdourian, M. S.
    Shah, N.
    Thompson, L. L.
    Reynolds, K.
    Chen, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : B11 - B11
  • [29] Minimizing adverse drug events in older patients
    Pham, Cung B.
    Dickman, Robert L.
    AMERICAN FAMILY PHYSICIAN, 2007, 76 (12) : 1837 - 1844
  • [30] Comparative Dose Response Modeling of Efficacy, Adverse Events and Discontinuation Rates in Neuropathic Pain
    Lobo, Evelyn D.
    Heathman, Michael A.
    Ebling, William F.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S39 - S40